美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Novo Nordisk A/S B Shares ADRhedged

22.95

-0.2529-1.09%

成交量：687

成交額：1.58萬

市值：390.15萬

市盈率：- -

高：23.27

開：23.27

低：22.95

收：23.20

52周最高：34.36

52周最低：19.00

股本：17.00萬

流通股本：17.00萬

量比：0.78

換手率：0.40%

股息：1.56

股息率：6.79%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

諾和諾德(NVO.US)：第二季度營業利潤受到美國340B返利撥備轉回的負面影響。

諾和諾德(NVO.US)：2026年第二季度調整後銷售額為784.9億丹麥克朗；調整後營業利潤為333.9億丹麥克朗。0

諾和諾德發布財報後，禮來股價上漲1.3%。

諾和諾德(NVO.US)：上調業績展望主要由GLP-1產品銷售預期提升推動。

諾和諾德：2026 年第二季度固定匯率下調整後銷售額增長 7%；固定匯率下調整後營業利潤增長 11%。

H1與諾和諾德達成合作，規模化推進人工智能驅動的臨床開發。

Hims & Hers Health面臨投資者訴訟調查

环球市场播报

肥胖藥市場競爭再升温，諾和諾德憑藉口服Wegovy重返與禮來的競爭賽道

老虎资讯综合

分析-隨着諾和諾德（Novo）奮力重返競爭行列，與禮來（Lilly）的抗肥胖之戰再度白熱化

ETF周報 | 2倍做多微軟ETF升逾45%；2倍做多亞馬遜ETF升逾34%；三倍做多富時中國ETF升逾17%

諾和諾德(NVO)股票7月31日盤中下跌8.75%：投資者必看的核心信息

TradingKey中文

諾和諾德跌超10%！創近五個月以來最大單日跌幅，宣佈心臟新藥臨床試驗失敗

TradingKey中文

美股異動 | 心臟病新藥試驗未達到主要終點諾和諾德(NVO.US)大跌近10%

美股開盤 | 三大指數集體上漲，亞馬遜升逾12%，蘋果跌超9%；存儲股板塊普漲，閃迪升逾8%

老虎资讯综合

心臟新藥試驗失敗！諾和諾德(NVO.US)股價盤前閃崩「減肥藥依賴症」陰雲加劇

諾和諾德股價因心臟病藥物試驗失敗暴跌9%

环球市场播报

盤前異動 | 諾和諾德盤前跌超9%，ZILTIVEKIMAB未展現預期優勢

老虎资讯综合

市場消息：諾和諾德的ZILTIVEKIMAB並未顯示出比安慰劑更低的梅毒風險。

諾和諾德(NVO.US)在更新ZEUS三期試驗進展後盤前下跌8.3%。

諾和諾德盤前跌超10%公司表示抗炎藥物Ziltivekimab在MACE風險降低方面與安慰劑相比未顯示出顯著差異。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/NVOH/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVOH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","market":"US","secType":"STK","nameCN":"Novo Nordisk A/S B Shares ADRhedged","latestPrice":22.95,"timestamp":1789588800000,"preClose":23.20291,"halted":0,"volume":687,"delay":0,"changeRate":-0.010899925914465038,"floatShares":170001,"shares":170001,"eps":0,"marketStatus":"盤前交易","change":-0.25291,"latestTime":"09-17 07:00:21 EDT","open":23.27,"high":23.27,"low":22.95,"amount":15839,"amplitude":0.013791,"askPrice":36.49,"askSize":100,"bidPrice":18.27,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789651800000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":22.95,"nav":23.263647,"aum":3954843.253647,"dividendRate":0.0679,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":23,"preClose":22.95,"latestTime":"16:15 EDT","volume":9,"amount":206.55,"timestamp":1789589700302,"change":0.05,"changeRate":0.002179,"amplitude":0},"volumeRatio":0.779264910902287,"impliedVol":0.243,"impliedVolPercentile":0.5862},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","floatShares":170001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.779264910902287,"shares":170001,"dividePrice":1.5583,"high":23.27,"amplitude":0.013791,"preClose":23.20291,"low":22.95,"week52Low":19,"pbRate":"--","week52High":34.36,"institutionHeld":0,"latestPrice":22.95,"eps":0,"divideRate":0.0679,"volume":687,"delay":0,"ttmEps":0,"open":23.27,"prevYearClose":27.4362,"prevWeekClose":23.4261,"prevMonthClose":24.5859,"prevQuarterClose":26.0576,"fiveDayClose":24.1612,"twentyDayClose":24.8729,"sixtyDayClose":25.0475},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOH\",params:#limit:5,,,undefined,":[{"date":"2026-09-16","symbol":"NVOH","amount":0.02979,"announcedDate":"2026-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-16","defaultRemindTime":1789565400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-23","payableDate":"2026-09-16","currency":"USD","dateTimestamp":1789531200000,"payDate":"2026-09-23"},{"date":"2026-06-16","symbol":"NVOH","amount":0.76666,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"NVOH","amount":0.27495,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"NVOH","amount":0.48798,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2025-09-16","symbol":"NVOH","amount":0.16566,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"Novo Nordisk A/S (B Shares) ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOH\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-16","recordDate":"2025-09-16","paymentDate":"2025-09-23","value":0.16566,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.48798,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.27495,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.76666,"currency":"USD"},{"executeDate":"2026-09-16","recordDate":"2026-09-16","paymentDate":"2026-09-23","value":0.02979,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOH\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657568331","title":"諾和諾德(NVO.US)：第二季度營業利潤受到美國340B返利撥備轉回的負面影響。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657568331","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657568331?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 00:40","pubTimestamp":1785861654,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","NVO","LU0154236417.USD","LU1093756168.USD","BK4599","BK4532","BK4588","IE00BKVL7J92.USD","LU1093756325.SGD","THNR","NVOX","NVOH","BK4007","OZEM","IE00BZ1G4Q59.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657568820","title":"諾和諾德(NVO.US)：2026年第二季度調整後銷售額為784.9億丹麥克朗；調整後營業利潤為333.9億丹麥克朗。0","url":"https://stock-news.laohu8.com/highlight/detail?id=2657568820","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657568820?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 00:36","pubTimestamp":1785861369,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["OZEM","NVOX","THNR","IE00BKVL7J92.USD","LU0154236417.USD","NVO","BK4599","NVOH","PPH","BK4532","LU1093756325.SGD","BK4585","LU1093756168.USD","IE00BZ1G4Q59.USD","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657847568","title":"諾和諾德發布財報後，禮來股價上漲1.3%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657847568","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657847568?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 00:35","pubTimestamp":1785861348,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0787776722.HKD","BK4599","SGXZ81514606.USD","LU2750360641.GBP","IE0004445015.USD","LU0106261372.USD","LU1623119135.USD","FTXH","LU1917777945.USD","LU2471134952.CNY","SGXZ57979304.SGD","SGXZ31699556.SGD","NVOX","IE00B4JS1V06.HKD","LU0456855351.SGD","SG9999014898.SGD","LU1814569148.SGD","IE00BKPKM429.USD","LU0354030511.USD","LU2602419157.SGD","SG9999015978.USD","LU0234572021.USD","LU2417539215.USD","LU1868836591.USD","LU2106854487.HKD","BK4581","MHIP","LU2168564149.EUR","LU2237443895.HKD","LU0289739699.SGD","LLY","LU2265009873.SGD","FHLC","IE00BZ1G4Q59.USD","LU0820561909.HKD","LU0964807845.USD","LU2089284900.SGD","PJP","GDOC","LU2361045086.USD","LU1064131342.USD","LU2491050071.SGD","IE00BN29S564.USD","LU2461242641.AUD","IE00BJJMRY28.SGD","LU1023059063.AUD","LU1712237335.SGD","LU2112291526.USD","SGXZ99366536.SGD","LU0096364046.USD","IE00BJJMRX11.SGD","LU0345770308.USD","LU0354030438.USD","LU0225283273.USD","LU0882574139.USD","LU2028103732.USD","LU2211815571.USD","LU2237443465.HKD","LU2087625088.SGD","LU2236285917.USD","LLYX","IE0005OL40V9.USD","ELIS","LU0109394709.USD","HRTS","LU1366192091.USD","IE00BKDWB100.SGD","LU0109391861.USD","IE00BJJMRZ35.SGD","LU1145028129.USD","BK4588","IE00BWXC8680.SGD","IXJ","LU0353189763.USD","LU0417517546.SGD","LU1093756325.SGD","LU1720051108.HKD","LU2361044949.HKD","LU2462591350.SGD","LU2471134523.USD","LU0058720904.USD","LU0353189680.USD","IHE","LU0823434740.USD","LU2237443549.SGD","LU1057294990.SGD","LU1989771016.USD","IE00B2B36J28.USD","SG9999014880.SGD","LU2108987350.USD","SG9999018865.SGD","LU2213496289.HKD","MEDX","LU0079474960.USD","LU0786609619.USD","IE00BKVL7J92.USD","SG9999017495.SGD","LU1974910355.USD","LU0889565916.HKD","ILDR","LU0174119429.USD","LU0094547139.USD","BK4007","SG9999018857.SGD","AGNG","SG9999015945.SGD","NVO","LU1069344957.HKD","LU2471134879.HKD","LU0882574055.USD","LU0640476718.USD","LU0345770993.USD","LU2237443382.USD","XLV","IE00B775H168.HKD","LU2168563687.JPY","IYH","LU0256863902.USD","LU2168564222.USD","SG9999014906.USD","LU0466842654.USD","LU0256863811.USD","LU0154236417.USD","LU0689472784.USD","LU1988902786.USD","LU2237443622.USD","LU2462157665.USD","MEDI","LU0316494557.USD","LU0471298777.SGD","LU2063271972.USD","LU1280957306.USD","WDNA","LU0114720955.EUR","LU2746668974.SGD","LU2456880835.USD","TMED","BK4532","IE00B7KXQ091.USD","LU0708995401.HKD","THNR","LLYZ","NVOH","LU0158827948.USD","LU0385154629.USD","CURE","CANC","LU1267930730.SGD","JDOC","LU1323610961.USD","IE00BK4W5L77.USD","LU0320765059.SGD","LU1127390331.HKD","LU1551013425.SGD","LU0820562030.AUD","SG9999015986.USD","IE00BFSS7M15.SGD","LU1979441026.SGD","LU0133085943.USD","LU0198837287.USD","LU2896262040.SGD","LU2552382215.SGD","VHT","LU1551013342.USD","LU2471134796.USD","LU1804176565.USD","PPH","GB00BDT5M118.USD","LU2750360997.AUD","LU0432979614.USD","LU0672654240.SGD","BK4516","LU1868837136.USD","LU1291159041.SGD","LU2023250504.SGD","IE00BFSS8Q28.SGD","IE0002141913.USD","LU0683600562.USD","IE00BJT1NW94.SGD","LU0823434583.USD","IE00BK4W5M84.HKD","OZEM","LU2357305700.SGD","IE0001KFT4U8.USD","LU0097036916.USD","LU0203201768.USD","LU0122379950.USD","LU2023251221.USD","LU0820561818.USD","IE00BJLML261.HKD","LU2237443978.SGD","LU2264538146.SGD","LU0823416689.USD","LU2491050154.USD","RXL","SG9999001176.SGD","LU2552382132.HKD","LU1720051017.SGD","LU0943347566.SGD","SG9999001176.USD","LU1035775433.USD","LU0320765992.SGD","LU2168564495.EUR","LU2271345857.HKD","LU0323591593.USD","LU1093756168.USD","LU2089984988.USD","LU1061106388.HKD","LLII","IE00BFTCPJ56.SGD","SG9999013999.USD","LU2360106947.USD","LU2023250330.USD","LU2324357040.USD","LU0006306889.USD","LU2468319806.SGD","LU0158827781.USD","SG9999014914.USD","LU2237438978.USD","TRUH","IE00B4R5TH58.HKD","LU1548497426.USD","ELIL","LU2746668461.USD","IE0004445239.USD","LU0471298694.HKD","LU1868836757.USD","LU0210536198.USD","LU0266013472.USD","LU1868836914.USD","BK4533","LU2111349929.HKD","LU2756315664.SGD","SG9999015952.SGD","LU1629891620.HKD","BK4585","IE0009355771.USD","LU0238689110.USD","LU0061475181.USD","LU1232071149.USD","LU1983299246.USD","LU2552382058.USD","LU2089283258.USD","LU2168564065.EUR","LU1868837300.USD","BK4534","LU2756315318.SGD","SGXZ51526630.SGD","IE00B1XK9C88.USD","LU2361044865.SGD","IE00B1BXHZ80.USD","LU2491049909.HKD","LU0203202063.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657056884","title":"諾和諾德(NVO.US)：上調業績展望主要由GLP-1產品銷售預期提升推動。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657056884","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657056884?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 00:35","pubTimestamp":1785861338,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["OZEM","BK4532","THNR","NVOX","LU0154236417.USD","BK4007","LU1093756168.USD","NVO","PPH","LU1093756325.SGD","NVOH","BK4588","IE00BZ1G4Q59.USD","BK4599","IE00BKVL7J92.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657568841","title":"諾和諾德：2026 年第二季度固定匯率下調整後銷售額增長 7%；固定匯率下調整後營業利潤增長 11%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657568841","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657568841?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 00:34","pubTimestamp":1785861263,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","BK4599","BK4585","NVO","OZEM","LU1093756168.USD","IE00BKVL7J92.USD","NVOH","LU0154236417.USD","BK4532","IE00BZ1G4Q59.USD","PPH","THNR","BK4588","NVOX","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656559761","title":"H1與諾和諾德達成合作，規模化推進人工智能驅動的臨床開發。","url":"https://stock-news.laohu8.com/highlight/detail?id=2656559761","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656559761?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 21:12","pubTimestamp":1785849134,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1093756168.USD","BK4585","PPH","BK4588","IE00BKVL7J92.USD","THNR","IE00BZ1G4Q59.USD","NVOX","BK4007","NVOH","NVO","OZEM","LU1093756325.SGD","LU0154236417.USD","BK4532","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656309306","title":"Hims & Hers Health面臨投資者訴訟調查","url":"https://stock-news.laohu8.com/highlight/detail?id=2656309306","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656309306?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 03:33","pubTimestamp":1785785580,"startTime":"0","endTime":"0","summary":"律师事务所Kessler Topaz Meltzer & Check， LLP宣布对Hims & Hers Health， Inc．发起调查，代表投资者调查该公司是否存在联邦证券法违规行为。当日盘前，制药公司诺和诺德宣布终止与Hims & Hers的合作伙伴关系，理由是该公司涉嫌非法大规模配制药物并进行欺骗性营销，将患者安全置于风险之中。诺和诺德还指出，Hims & Hers未能遵守禁止大规模销售复方药物的法律。受此消息影响，Hims & Hers股价在2025年6月23日盘中暴跌超20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-04/doc-inimascz5644442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["THNR","BK4599","OZEM","LU0154236417.USD","NVOH","LU1093756325.SGD","BK4007","BK4585","LU1093756168.USD","BGIA","IE00BKVL7J92.USD","NVO","IE00BZ1G4Q59.USD","NVOX","BK4532","BK4588","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132732205","title":"肥胖藥市場競爭再升温，諾和諾德憑藉口服Wegovy重返與禮來的競爭賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=1132732205","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132732205?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 13:44","pubTimestamp":1785735844,"startTime":"0","endTime":"0","summary":"诺和诺德与礼来在肥胖药市场的竞争正进入关键阶段。过去两年，礼来凭借Zepbound（替尔泊肽）在美国市场快速扩大份额，股价持续上涨；而诺和诺德则因利润预警、管理层调整以及竞争压力加剧，股价大幅回落。不过，随着口服版Wegovy在美国上市后需求超预期，诺和诺德开始逐步反击，并通过法律行动和加大商业化投入寻求恢复市场信心。两家公司将于8月5日公布财报，市场关注重点将转向肥胖药需求持续性、市场份额变化以及未来增长空间。分析人士认为，肥胖药市场规模预计将在未来十年突破千亿美元，但最终胜负将取决于药物疗效、商业化能力以及企业能否维持长期增长。","market":"us","thumbnail":"https://community-static.tradeup.com/news/b325d3752f8fcafc403af6145a5cd0d7","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/b325d3752f8fcafc403af6145a5cd0d7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLYX","ELIS","ELIL","NVOH","NVO","LLII","NVOX","LLY","LLYZ"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2656409403","title":"分析-隨着諾和諾德（Novo）奮力重返競爭行列，與禮來（Lilly）的抗肥胖之戰再度白熱化","url":"https://stock-news.laohu8.com/highlight/detail?id=2656409403","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656409403?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 13:01","pubTimestamp":1785733262,"startTime":"0","endTime":"0","summary":"尽管诺和诺德近年来在GLP-1注射剂领域市场份额有所下滑，但这家丹麦减肥药制造商正从其新推出的Wegovy减肥药中获得提振，该产品在与礼来公司近期推出的Foundayo的竞争中保持着领先地位。诺和诺德力图“大放异彩”诺和诺德与礼来之间的竞争已蔓延至法庭。礼来公司已否认了这些指控。他表示，诺和诺德需要通过在肥胖治疗领域达成合作协议，才能说服市场相信他们能够与礼来公司长期竞争。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL4T4400AY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","IE00B4JS1V06.HKD","LU0466842654.USD","LU0820561818.USD","BK4533","TMED","BK4516","IE00B1BXHZ80.USD","OZEM","LU1979441026.SGD","LU2168564495.EUR","LU1280957306.USD","SGXZ57979304.SGD","LU2746668461.USD","LU0238689110.USD","LU0708995401.HKD","LU2461242641.AUD","MHIP","LU0353189680.USD","LU0456855351.SGD","LU2237443465.HKD","SG9999015978.USD","CURE","LU0345770993.USD","LU0672654240.SGD","LU1093756325.SGD","LU2237438978.USD","IE00BK4W5L77.USD","LU2491049909.HKD","NVOH","LU0203202063.USD","IE00BFSS8Q28.SGD","IE00BK4W5M84.HKD","LU1804176565.USD","LU2168564065.EUR","SGXZ81514606.USD","LU1868836914.USD","LU2112291526.USD","IE00BJJMRY28.SGD","LU2237443382.USD","LU2324357040.USD","BK4599","PJP","LU0471298777.SGD","LU0006306889.USD","LU0786609619.USD","LU0820562030.AUD","BK4532","LU0096364046.USD","LU0114720955.EUR","IE0004445015.USD","LU1267930730.SGD","LU2896262040.SGD","LU2023250330.USD","LU2168563687.JPY","BK4007","LU0417517546.SGD","LU2089283258.USD","LU2108987350.USD","LU2265009873.SGD","SG9999014898.SGD","LU0964807845.USD","LU0353189763.USD","LU2361044865.SGD","LU0225283273.USD","LU1720051017.SGD","LU1057294990.SGD","GB00BDT5M118.USD","LU1629891620.HKD","LU0266013472.USD","LU2237443978.SGD","LU2168564149.EUR","LU2236285917.USD","LU2023250504.SGD","LU2756315664.SGD","SG9999014914.USD","LU1366192091.USD","LU2746668974.SGD","LU0354030438.USD","IE00BJT1NW94.SGD","LU0787776722.HKD","LU0316494557.USD","IHE","LU0058720904.USD","LU2462591350.SGD","IE00BFSS7M15.SGD","ILDR","LU2456880835.USD","LU2750360997.AUD","LU0640476718.USD","RXL","LU1093756168.USD","LU1061106388.HKD","IXJ","LU0432979614.USD","LLYZ","LU2089984988.USD","LU0079474960.USD","LU0158827781.USD","LU2237443895.HKD","LU2462157665.USD","WDNA","LLII","LU1868837136.USD","NVOX","SG9999015986.USD","PPH","LU0094547139.USD","LU0106261372.USD","LU2089284900.SGD","LU0133085943.USD","LU1623119135.USD","LU2111349929.HKD","LU1712237335.SGD","ELIL","LU2213496289.HKD","LU2087625088.SGD","LU2360106947.USD","IE00B1XK9C88.USD","LU2756315318.SGD","LU2063271972.USD","IE00BKDWB100.SGD","GDOC","LU1868837300.USD","LU2237443622.USD","LU1127390331.HKD","LU1814569148.SGD","LU2491050071.SGD","AGNG","LU2361045086.USD","LU1323610961.USD","IE00B7KXQ091.USD","SGXZ31699556.SGD","LU2602419157.SGD","SG9999014880.SGD","LU2271345857.HKD","LU0689472784.USD","LU1974910355.USD","LU0109391861.USD","LU2168564222.USD","IE0004445239.USD","IE00B4R5TH58.HKD","LU1232071149.USD","IE0001KFT4U8.USD","IE00BJJMRX11.SGD","LU0820561909.HKD","LLYX","LU0320765992.SGD","LU0882574055.USD","LU0345770308.USD","LU1988902786.USD","NVO","LU1551013342.USD","SG9999015945.SGD","SG9999015952.SGD","LU0320765059.SGD","LU0109394709.USD","VHT","LU1023059063.AUD","LU0174119429.USD","LU0889565916.HKD","LU0256863902.USD","MEDX","SGXZ51526630.SGD","LU1551013425.SGD","SGXZ99366536.SGD","LU2471134879.HKD","ELIS","BK4588","IE00B775H168.HKD","LU1983299246.USD","LU2552382132.HKD","TRUH","LU1989771016.USD","LU0323591593.USD","LU1291159041.SGD","LU2023251221.USD","SG9999001176.SGD","LU2028103732.USD","LU2361044949.HKD","SG9999018857.SGD","JDOC","LU2471134796.USD","THNR","LLY","IE00BZ1G4Q59.USD","XLV","LU1145028129.USD","SG9999018865.SGD","SG9999001176.USD","LU2264538146.SGD","LU0683600562.USD","LU0823434583.USD","LU0234572021.USD","LU1868836757.USD","LU2237443549.SGD","LU0154236417.USD","LU2471134952.CNY","LU0097036916.USD","HRTS","LU0198837287.USD","BK4581","LU2750360641.GBP","LU1069344957.HKD","LU2211815571.USD","IE00BWXC8680.SGD","IE00B2B36J28.USD","LU0158827948.USD","LU0823416689.USD","SG9999017495.SGD","IE0005OL40V9.USD","IE0009355771.USD","LU0256863811.USD","IE00BFTCPJ56.SGD","LU2471134523.USD","LU2357305700.SGD","IYH","LU0122379950.USD","LU2417539215.USD","BK4585","LU1720051108.HKD","LU0385154629.USD","MEDI","IE00BKVL7J92.USD","LU2106854487.HKD","LU0354030511.USD","SG9999014906.USD","IE00BN29S564.USD","LU2468319806.SGD","LU0471298694.HKD","FTXH","CANC","LU1035775433.USD","LU1548497426.USD","LU2491050154.USD","LU0210536198.USD","LU1868836591.USD","LU0943347566.SGD","IE00BJJMRZ35.SGD","LU0203201768.USD","LU0289739699.SGD","LU0882574139.USD","LU1064131342.USD","LU0061475181.USD","LU2552382215.SGD","SG9999013999.USD","LU2552382058.USD","LU0823434740.USD","BK4534","LU1917777945.USD","IE00BJLML261.HKD","IE00BKPKM429.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193230055","title":"ETF周報 | 2倍做多微軟ETF升逾45%；2倍做多亞馬遜ETF升逾34%；三倍做多富時中國ETF升逾17%","url":"https://stock-news.laohu8.com/highlight/detail?id=1193230055","media":"ETF周报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193230055?lang=zh_tw&edition=fundamental","pubTime":"2026-08-02 06:30","pubTimestamp":1785623400,"startTime":"0","endTime":"0","summary":"本周ETF层面，科技龙头相关杠杆产品领涨，做空贵金属与原油的产品亦录得涨幅。美股ETF本周涨幅Top52倍做多MSFT ETF-Direxion上涨45.11%。该产品两倍做多比特币矿企Riot Platforms，底层公司股价走弱，杠杆机制放大本周跌幅。2倍做多QCOM ETF-GraniteShares下跌22.65%。大盘指数ETF涨幅Top 5三倍做多富时中国ETF-Direxion上涨17.22%。二倍做多富时中国50ETF上涨10.49%。大宗商品ETF涨幅Top 5做空黄金ETN(德银)上涨8.45%。三倍做空半导体ETF-Direxion Daily上涨5.28%。两倍做空房地产ETF-ProShares上涨3.97%。债券ETF涨幅Top 5First Trust Emerging Markets Local Currency Bond ETF上涨1.21%。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAI","GLDY","SOXS","LU2602419157.SGD","IE0004445239.USD","LU1791710582.SGD","IE00B19Z3581.USD","LU1162221912.USD","LU0726765562.USD","LU1670710588.SGD","LU1861215975.USD","FNCL","LU0545562505.USD","BK4596","LU2087621335.USD","LU0788109477.HKD","BK4551","IE00BN8TJ469.HKD","LU0130103400.USD","LU1979441026.SGD","CQQQ","TDV","LU0456855351.SGD","RGTC","LU0256863902.USD","LU1974910355.USD","LU0795875169.SGD","LU0965508806.USD","LU0106261372.USD","XLK","SG9999018857.SGD","SGXZ99366536.SGD","LU1551013425.SGD","LU1059921491.USD","LU1868837300.USD","LU0689626769.HKD","LU1066051498.USD","IE00BZ1G4Q59.USD","YSPY","LU0964807845.USD","IE00BWXC8680.SGD","LU1400636657.SGD","LU1914381329.SGD","SG9999015978.USD","LU2896262040.SGD","LU1228905540.USD","LU1221951129.SGD","YXI","LU0823434583.USD","LU1623119135.USD","LU0109391861.USD","SGXZ80539844.SGD","AMZZ","LU2404859741.USD","LU0107464264.USD","02823","LU0640476718.USD","LU1069344957.HKD","LU1280957306.USD","FXL","LU0957791311.USD","IE00BJJMRY28.SGD","LU1267930573.SGD","LU0742534661.SGD","LU0320765059.SGD","IE00B5949003.HKD","IE00BSNM7G36.USD","LU0345768153.USD","LU0417517546.SGD","LU0949170426.SGD","LU1951200564.SGD","LU2250418816.HKD","WUGI","FNGZ","IXN","LU0820562030.AUD","LU0823421333.USD","LU2168564495.EUR","SPUU","LU0642271901.SGD","LU0154236417.USD","LU0238689110.USD","XNTK","LU0289739343.SGD","LU1323610961.USD","IE00BMPRXN33.USD","HK0000914660.USD","IE000YTNTUN2.SGD","LU2506952097.USD","LU1582987324.SGD","LU0081259029.USD","LU0557290698.USD","LU0661504455.SGD","MSFU","AAAU","LU1564329032.USD","NULC","RING","LU2097829019.USD","LU1697837992.HKD","IE00B5TLWC47.USD","UDOW","IE0005OL40V9.USD","LU1935043023.USD","LU2125154935.USD","LU2430703095.HKD","IYG","FXP","LU0820561909.HKD","LU0072462426.USD","LU1145028129.USD","LU1121112475.USD","LU2543165471.USD","LU2089985449.USD","LU1400636491.USD","NVOH","LU0203347892.USD","LU0314104364.USD","LU1934455277.USD","LU1236620750.USD","BK4538","SPYQ","KWEB","GDX","LU2092627202.USD","BK4532","LU1868836591.USD","LU0070217475.USD","SNPE","IE0003U64NQ7.SGD","LU0251131958.USD","GDXY","GLDM","LU1244550577.SGD","LU0265550946.USD","YANG","ASHS","XX25.UK","LU0143551892.USD","LU0949170772.SGD","LU0211326755.USD","BK4516","LU1043141396.HKD","WANT","LU0225283273.USD","SG9999000418.SGD","LU1935042488.USD","LU0006306889.USD","SPDN","LU1201861165.SGD","LU2237957902.USD","GB00B4QBRK32.GBP","LU0070302665.USD","LU0211331839.USD","NVTC","LU0323240290.USD","FDTX","BK4604","LU1934455863.HKD","LU1032955483.USD","CEF","COZX","BK4515","LU1235294995.USD","LU1267930490.SGD","LU0149725797.USD","DGZ","LU1267930813.SGD","LU2362541273.HKD","SGXZ31699556.SGD","LU0879622024.SGD","BK4600","LU1066051811.HKD","LU1261432733.SGD","LU1988902786.USD","LU2491050071.SGD","LU1923622614.USD","LU1582986359.USD","BK4605","LU1861220033.SGD","ONTX","LU0310800379.SGD","USG","BK4567","LU0963586101.USD","LU2756315318.SGD","LU0061474960.USD","LU1201861249.SGD","IE00BJTD4V19.USD","LU0251132253.USD","LU2720916845.USD","BK4577","BLOX","BK4220","IE00BYXW3230.USD","LU0310799852.SGD","LU2023250504.SGD","YGLD","AIFD","LU1861127337.USD","LU0511384066.AUD","LU0708994859.HKD","LU2237443549.SGD","LU1642822529.SGD","LU0648001328.SGD","BK4585","LU1506573853.SGD","NBIC","BK4559","LU1267930730.SGD","LU2357627491.SGD","IE000M9KFDE8.USD","CHAU","IE00BVYPNQ40.USD","SG9999001077.SGD","HK0000819398.USD","CGGO","LU0724617625.USD","LU0882574139.USD","LU1670711040.USD","LU0175139822.USD","02843","LU2168564149.EUR","XW","LU0215105999.USD","IETC","LU2244417387.USD","LU1720051017.SGD","LU2237443465.HKD","TRUF","SG9999014542.SGD","SG9999014880.SGD","LU0211328371.USD","LU1232071149.USD","LU1035775433.USD","BK4576","LU0823417737.USD","LU0096364046.USD","IE00B775SV38.USD","IE00BFSS7M15.SGD","LU1951198990.SGD","LU2100268510.USD","FXI","LU1188199696.SGD","LU1935042991.SGD","LU1868836757.USD","IBLC","LU0390134368.USD","LU1153585028.USD","LU1852331112.SGD","BK4592","DZZ","LU0234572021.USD","DULL","LU1334329650.SGD","LU1202635105.USD","LU1585245621.USD","LU0823411888.USD","LU2097344431.USD","LU0130102774.USD","LU3102509885.SGD","IE00BBT3K403.USD","MVV","DRV","LU0127658192.USD","LU0889566641.SGD","LU2750360641.GBP","LU0784385840.USD","OGIG","CHPX","FTXO","IE000SO60NU8.SGD","ILDR","LU1804176565.USD","LU1721428933.USD","LEMB","LU0795875086.SGD","LU1235295455.SGD","LU2592432038.USD","LU2237957811.SGD","LU2317271919.USD","LU1228905037.USD","LU1868837136.USD","LU2237443622.USD","LU2433249047.HKD","BTGD","GDXD","LU2242649171.HKD","LU1316542783.SGD","CHAT","EGGY","HIBL","LU1236620834.HKD","WLDR","LU1814569148.SGD","LU0496365809.HKD","LU2750360997.AUD","IE00B1XK9C88.USD","IE0004086264.USD","LU0267386448.USD","LU0198837287.USD","LU1803068979.SGD","BK4141","LU2456880835.USD","BK4512","SG9999015341.SGD","SG9999015945.SGD","LU0476273544.USD","LU0345774391.USD","SOXQ","LU2275660780.HKD","BK4581","LU2023251221.USD","LU0683600562.USD","HULL","SIMX","LU0171293334.USD","EMLC","BK4575","LU1989773731.SGD","LU2552382058.USD","LU0323591593.USD","CWEB","CMAG","XPP","LU0203202063.USD","LU1548497426.USD","SHOC","LU2023250843.SGD","LU2999663052.SGD","IE00B7KXQ091.USD","GDXJ","LU2264538146.SGD","LU2125909247.SGD","LU1301847155.USD","LU2360108059.USD","XLY","BK4595","HK0000914686.HKD","UYM","LU0061475181.USD","LU2286300806.USD","BK4528","LU1244550494.USD","LU0912757837.SGD","IE00B19Z3B42.SGD","LU2413666699.HKD","LU2168564065.EUR","LU0094547139.USD","LU0494093205.USD","LU1894683264.USD","LU0985320562.USD","BK4534","LU1435385759.SGD","LU0096362180.USD","IE0000B7K699.USD","IE00BDRTCR15.USD","BNDW","LU0553294199.USD","LU1244550221.USD","LU1803068623.USD","BK4207","SPYU","IVV","LU2506951958.HKD","GAMR","LU0158827781.USD","LU0348723411.USD","LU0157215616.USD","SG9999014575.USD","LU2108987350.USD","VFH","LU0353189680.USD","LU0048573561.USD","LU0994945656.USD","LU1066051225.USD","SPY","AIQ","PGJ","SG9999014559.SGD","IE000W1ABFV2.USD","LU0302445910.USD","LU1791710400.SGD","LU1670711123.USD","LU2237443978.SGD","IAUM","LU1712237335.SGD","LU2111349929.HKD","ROM","LU0345769128.USD","LU1894683348.USD","LU2210149790.SGD","BK4587","LU0133085943.USD","TRFK","LU0823421416.USD","LU2191332357.HKD","LU2237443895.HKD","LU0889565833.HKD","LU0106831901.USD","LU0289961442.SGD","TYLG","LU0210533765.USD","TEUP","LFGY","LU0029864427.USD","FGDL","LU0444971666.USD","LU2552382132.HKD","LU1917777945.USD","FAI","IE0009356076.USD","TDIV","LU0256863811.USD","LU1935042215.USD","BK4548","LU0274383776.USD","LU0234570918.USD","LU0545039389.USD","LU1196500208.SGD","LU2362541513.USD","LU0251142724.SGD","IE00B3S45H60.SGD","NVOX","BK4525","LU1883839398.USD","BK4554","LU1037948541.HKD","LU2065171311.SGD","UPRO","SIVR","LU2430703178.SGD","SG9999002224.SGD","SPXL","IE000ITXATA3.USD","LU2403377893.USD","BK4007","IE000MB6IJN5.SGD","LU2954938101.SGD","BK4598","LU0323239441.USD","IE00BLSP4239.USD","LU0170899867.USD","LU1674673691.USD","LU0345770308.USD","LU0289960550.SGD","DBC","LU0056508442.USD","IE0004091025.USD","SOXX","SG9999001424.SGD","LU0211326839.USD","SPXS","LU0787776722.HKD","LU1923623000.USD","SG9999014906.USD","BK4097","LU1400636574.HKD","JPO","SRS","SG9999017495.SGD","SGXZ23171101.USD","LU1127390331.HKD","LU1116320901.HKD","LU2087625088.SGD","SG9999014567.USD","ASHR","BK4122","IE00B19Z8W00.USD","LU2506951875.HKD","DMAX","CHPS","LU0894486033.HKD","LU0957808578.USD","LU2106854487.HKD","BK4527","IE00B775H168.HKD","SGXZ51526630.SGD","SG9999018865.SGD","IAUI","LU0345774631.USD","IAU","LU1670627923.USD","VOO","IE00BJJMRX11.SGD","LU2360106780.USD","LU1564329461.SGD","LU2063271972.USD","LU0203201768.USD","FDN","LU2764262908.HKD","LU1084165304.USD","82823","LU2298321311.HKD","LU2237443382.USD","SLV","LU1732800096.USD","XLF","BK4612","LU0345768740.USD","LU1839511570.USD","LU0784385170.HKD","RULE","LU2211817866.USD","LU2236285917.USD","CNEQ","LU0960925559.SGD","LU2357305700.SGD","IE00BKVL7J92.USD","LU1732799900.SGD","LU0138981039.USD","IE00B4YYXB79.USD","IGLD","LU0345770993.USD","LU0077335932.USD","LU2210150020.SGD","LU2420271590.USD","HK0000304797.USD","LU2083900584.USD","LU0426412945.USD","EMSF","LU0690374615.EUR","BK4507","LU1934455194.USD","LU2065169927.USD","IE00BQXX3C00.GBP","LU0472753341.HKD","LU0690374961.EUR","LU2637965513.SGD","DGP","LU0095938881.EUR","SG9999015952.SGD","LU0048584097.USD","LU2361044865.SGD","GLD","OUNZ","BK4503","LU0174119429.USD","LU1571399168.USD","LU0072461881.USD","LU0868494708.USD","LU0061474705.USD","LU0124676726.USD","EFIV","IE00BMPRXQ63.HKD","LU2462591277.SGD","SG9999002232.USD","LU0861579265.USD","LU1815336760.USD","BK4566","HBMX","USXF","LU0648000940.SGD","LU1582986433.USD","LU2102340556.USD","LU1989772923.USD","LU2213496289.HKD","LU2347655073.USD","GOAU","SPYM","LU1670628061.USD","LU1564329115.USD","LU1670710661.SGD","LU1989764664.SGD","LU2756315664.SGD","IE00BJLML261.HKD","LU1868836914.USD","PFXF","SG9999015986.USD","LU2413666426.HKD","IE00B19Z9505.USD","LU0158827948.USD","IE00BFXG1179.USD","DRAG","BKCH","LU1778281490.HKD","LU2746668461.USD","LU2746668974.SGD","IE00B1BXHZ80.USD","LU0320765489.SGD","LU0823434740.USD","LU1564329628.SGD","LU2860962120.EUR","PSI","LU1116320737.USD","LU0208291251.USD","SMH","LU0128525929.USD","LU0426417589.USD","SGDM","LU0082616367.USD","LU2505996509.AUD","JNUG","LU0314106906.USD","BK4023","BK4588","LU1551013342.USD","MCHI","LU0109392836.USD","ONLN","OSSL","LU0719512351.SGD","LU0784384876.USD","SPXU","SG9999015358.SGD","LU0738911758.USD","IE00BLSP4452.SGD","GLL","LU2048586759.USD","SMAX","LU0868494617.USD","IE00B4JS1V06.HKD","KGLD","SAA","IE00BQXX3F31.USD","LU0265550359.USD","LU0210528500.USD","LU0347712357.USD","LU0266013472.USD","LU1043141123.HKD","MIDU","LU1181866309.USD","LU1066053197.SGD","YINN","FEMB","ALA","LU0211327993.USD","LU0528227936.USD","SDS","BK4533","LU0353189763.USD","HK0000304805.HKD","IE0004445015.USD","LU0871640123.AUD","LU2471134523.USD","FTEC","LU1366192091.USD","LU0354030511.USD","LU0395794307.EUR","DAPP","LU1069347547.HKD","FTXL","BK4614","LU0080751232.USD","LU2471134879.HKD","LU2133065610.SGD","DIA","LU0757359954.USD","LITC","LU0971096721.USD","LU1003077747.HKD","LU1429558221.USD","LU0210536198.USD","LU2089284900.SGD","LU0820561818.USD","GBUG","LU2023250330.USD","MMAX","LU1674673428.USD","IE0034235303.USD","LU1645745479.HKD","LU2148611432.USD","DOG","SH","GOLY","IE0034235188.USD","LU0316494557.USD","BOBP","CLIX","LU0345769631.USD","IE00BK4W5M84.HKD","LU2065170008.USD","LU2491049909.HKD","LU2265009873.SGD","DUST","GDXU","LU0689472784.USD","LU0069063385.USD","IE00BJTD4N35.SGD","BAR","LU0053666078.USD","LU2168563687.JPY","LU2168564222.USD","LU2471134796.USD","LU2362540622.SGD","DXD","UMDD","IE0001KFT4U8.USD","LU2047632596.USD","TFNS","LU1221951046.USD","LU2458330169.SGD","DRMY","ZSL","LU1989763005.USD","VRC","FLCH","LU0057025933.USD","LU0097036916.USD","LU0976567544.SGD","LU1633808545.USD","82843","IE00BGHQDM52.EUR","LU1035773651.USD","LU1670756490.USD","IE00B3SWFQ91.USD","LU2028103732.USD","LU2430703251.USD","LU2506952170.USD","PALL","LU1935043536.SGD","DISK","LU0312595415.SGD","LU1823568750.SGD","LU2271345857.HKD","PHYS","BK7050","IE00BKPKM429.USD","BK4535","IE0009G5SDU7.USD","LU2089283258.USD","LU2931357623.SGD","LU0792757196.USD","LU2092937221.SGD","IE00B7SZLL34.SGD","SPYH","LU2347655156.SGD","AGQ","SG9999004303.SGD","LU0942090050.USD","LU0965509010.AUD","RTH","LU2237438978.USD","AIS","EBND.AU","LU1718418525.SGD","SHNY","IE00BDCRKT87.USD","BK4561","LU2505996681.GBP","LU2125154778.USD","ARTY","BK4543","IE00BYQQ9H92.USD","BK4553","LU1989772840.SGD","LU2242650005.HKD","LU2054465674.USD","BK4579","SSO","LU2290526834.HKD","LU0289941410.SGD","LU2461242641.AUD","LU1119994496.HKD","LU1880398554.USD","DDM","GB00BDT5M118.USD","LU2077746001.SGD","KBWB","JGRO","LU2211815571.USD","IE0034235295.USD","LU2381873111.SGD","82822","LU1064131342.USD","LU0823417653.USD","LU2764263039.SGD","SPTE","IE000KEQY171.SGD","LU1880398471.USD","SDOW","LU1366333091.USD","LU2462157665.USD","LU0079474960.USD","LU0965509101.SGD","LU1037948897.HKD","LU1074936037.SGD","LU1815333072.USD","LU2065171402.SGD","LU2462591350.SGD","SG9999014898.SGD","LU2092937148.SGD","LU2361045086.USD","LU2360107168.USD","SGXZ81514606.USD","LU1861559042.SGD","IE00BK4W5L77.USD","LU0784383803.USD","LU1691799644.USD","02822","GB00B4LPDJ14.GBP","BGLD","LU0672654240.SGD","LU2471134952.CNY","IE00BMPRXR70.SGD","IE00BQXX3D17.EUR","IE00BFSS8Q28.SGD","BK4504","LU1668664300.SGD","IE0002270589.USD","LU2491050154.USD","UGL","IE00B19Z8X17.USD","LU0354030438.USD","LU2552382215.SGD","BK4573","LU1046421795.USD","IE000F7OJYX1.SGD","LU0757359368.USD","LU2041044095.USD","LU1720051108.HKD","LU1861558580.USD","LU0980610538.SGD","LU1629891620.HKD","LU0708995401.HKD","LU1989764748.USD","LU1430594728.SGD","LU0859254822.USD","LU0308772762.SGD","LU0466842654.USD","LU0950375773.USD","LU2404859667.USD","LU1582987597.SGD","LU2361044949.HKD","EBND","LU1032466523.USD","DBP","IE00BN29S564.USD","LEGR","LU2125909593.SGD","LU2764263203.CNY","SGOL","PTF","UYG","ETNG","LU0320765646.SGD","IE00BKDWB100.SGD","VGT","LU0965509283.SGD","LU0203345920.USD","LU0187121727.USD","LU0943347566.SGD","LU1363072403.SGD","LU2452424414.USD","LU1496350171.SGD","LU0786609619.USD","HK0000532082.HKD","IGV","LU2487616109.SGD","LU2097344357.USD","IE00BHPRN162.USD","SG9999014914.USD","LU1340139317.AUD","LU2463028550.USD","BK4524","BK4550","LU2417539215.USD","LU0444973449.USD","IE00BFXG0V08.USD","LU0276348264.USD","LU2247934214.USD","LU0894485498.HKD","LU0162691827.USD","IE000WAW04H5.SGD","LU1983260115.SGD","LU2326559502.SGD","IXG","LU0342679015.USD","LU2360032135.SGD","LU2458330243.SGD","JDST","TTXU","IYF","LU0011850046.USD","IE000BZT7R73.USD","IE00BVYPNP33.GBP","LU1496350502.SGD","SGXZ44715902.SGD","LU2095319765.USD","SCO","LU2279689827.SGD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2656398139","title":"諾和諾德(NVO)股票7月31日盤中下跌8.75%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2656398139","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656398139?lang=zh_tw&edition=fundamental","pubTime":"2026-08-01 00:16","pubTimestamp":1785514597,"startTime":"0","endTime":"0","summary":"• 由于季度指引令人失望且竞争压力加剧，诺和诺德股价下跌。\n• 运营成本上升和供应链受阻正对该公司的利润率产生负面影响。\n• 围绕美国药品定价的立法不确定性加剧了对其未来营收增长的担忧。","market":"us","thumbnail":"https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262067948-market-movers-nvo-20260731","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154236417.USD","IE00BZ1G4Q59.USD","THNR","BK4588","PPH","BK4532","LU1093756168.USD","NVOX","IE00BKVL7J92.USD","NVOH","BK4599","LU1093756325.SGD","BK4007","OZEM","BK4585","NVO"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2656398133","title":"諾和諾德跌超10%！創近五個月以來最大單日跌幅，宣佈心臟新藥臨床試驗失敗","url":"https://stock-news.laohu8.com/highlight/detail?id=2656398133","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656398133?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 23:41","pubTimestamp":1785512495,"startTime":"0","endTime":"0","summary":"美东时间7月31日，诺和诺德（NVO）一度跌超10%，创自2026年2月23日以来最大单日跌幅，截至发稿，仍跌8.84%，报47.05美元。据悉，诺和诺德周五宣布，其备受关注的在研心脏新药ziltivekimab在一项大型后期临床试验中未能达到主要终点。","market":"fut","thumbnail":"https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/analysis/stocks/us-stock/262067893-novo-nordisk-nvo-crash-10-percent-ziltivekimab-heart-drug-zeus-trial-fails-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","THNR","OZEM","IE00BKVL7J92.USD","BK4585","NVO","NVOH","LU1093756168.USD","LU0154236417.USD","BK4588","LU1093756325.SGD","BK4599","BK4007","BK4532","IE00BZ1G4Q59.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655362997","title":"美股異動 | 心臟病新藥試驗未達到主要終點 諾和諾德(NVO.US)大跌近10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655362997","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655362997?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 22:16","pubTimestamp":1785507386,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BZ1G4Q59.USD","BK4007","BK4588","IE00BKVL7J92.USD","LU0154236417.USD","LU1093756325.SGD","NVO","NVOX","OZEM","THNR","PPH","NVOH","BK4599","BK4532","BK4585","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168627446","title":"美股開盤 | 三大指數集體上漲，亞馬遜升逾12%，蘋果跌超9%；存儲股板塊普漲，閃迪升逾8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168627446","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168627446?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 21:31","pubTimestamp":1785504670,"startTime":"0","endTime":"0","summary":"7月31日，美股三大指数开盘集体上涨，道指涨0.48%，纳指涨0.87%，标普500涨0.5%。存储股板块， 闪迪涨超8%，SK海力士、希捷涨超7%， 美光涨超5%；亚马逊涨超12%，AWS以37%的超预期增速回应AI烧钱质疑，市场无视现金流转负、资本开支上调；苹果跌超9%，上季iPhone收入增22%略超预期，但服务和中国市场业绩逊色，示警供应短缺伤害；诺和诺德跌近8%，公布ZEUS心血管3期试验主要结果，Ziltivekimab在MACE风险降低方面与安慰剂相比未显示出显著差异。","market":"us","thumbnail":"https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNDG","UDN","AZYY","AAPY","CNAV","STX","LU0054578231.USD","AMZN","LU2290526834.HKD","SSO","BK4170","07709","SNDU","IVV","HYNX","MUU","SKUU",".IXIC","SPXL","AMZY","SPYQ",".DJI","APLY","AAPX","BK4588","DRAM","AAPU","SNDC","UUP","SPY","AMZZ","AMZD","SNDK","MUD","MMAX","SKHX","SNDQ","AAPW","AMZU","MU","MUYY","VOO","DMAX",".SPX","SKHZ","AAPB","SPUU","AMZP","AMZW","SH","YSPY","SDOW","NVOH","LU0963586101.USD","SK","SKDD","LU2360107168.USD","SDS","MIC","SPYM","MUZ","PTF","UPRO","SKHY","DXD","NVO","SKHU","SPYU","DOG","LU1861215975.USD","HIBL","AAPD","LU1861220033.SGD","SPYH","SNXX","MULL","SMAX","SPXS","UDOW","AAPL","NVOX","SPDN","DIA","RAM","DDM","SPXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655436948","title":"心臟新藥試驗失敗！諾和諾德(NVO.US)股價盤前閃崩 「減肥藥依賴症」陰雲加劇","url":"https://stock-news.laohu8.com/highlight/detail?id=2655436948","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655436948?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 20:54","pubTimestamp":1785502475,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，丹麦制药巨头诺和诺德遭遇重大研发挫折，该公司周五宣布，其备受关注的在研心脏新药ziltivekimab在一项大型后期临床试验中未能达到主要终点，消息导致其股价盘中一度暴跌逾10%。安全性方面，两组总体不良事件发生率相近，但ziltivekimab组的严重感染发生率更高，总体死亡率则无差异。此次主要终点未达成，对这家丹麦制药商而言无疑是又一次打击。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1474849.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4599","NVO","BK4532","LU0154236417.USD","BK4588","LU1093756168.USD","NVOH","BK4007","OZEM","IE00BKVL7J92.USD","NVOX","LU1093756325.SGD","PPH","BK4585","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655366893","title":"諾和諾德股價因心臟病藥物試驗失敗暴跌9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655366893","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655366893?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 20:05","pubTimestamp":1785499500,"startTime":"0","endTime":"0","summary":"诺和诺德公司表示，其一项针对心脏病药物的后期临床试验未能比安慰剂更有效地减少重大心血管事件，该公司股价随即一度暴跌10%。诺和诺德在周五的一份声明中称，虽然其实验性药物ziltivekimab确实显示出一些生物学效应，但并未转化为对特定疾病患者在统计学上有意义的MACE降低——MACE定义为心血管死亡、非致命性心脏病发作或非致命性中风。诺和诺德在哥本哈根上市的股票最后报价下跌8.6%，其美国存托凭证在盘前交易中下跌9.8%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-31/doc-iniktcvf1201961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","NVOH","OZEM","BK4588","BK4532","BK4007","LU1093756325.SGD","IE00BZ1G4Q59.USD","LU1093756168.USD","PPH","THNR","LU0154236417.USD","NVOX","BK4599","NVO","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169208669","title":"盤前異動 | 諾和諾德盤前跌超9%，ZILTIVEKIMAB未展現預期優勢","url":"https://stock-news.laohu8.com/highlight/detail?id=1169208669","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169208669?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:36","pubTimestamp":1785497783,"startTime":"0","endTime":"0","summary":"7月31日，诺和诺德盘前跌超9%，报46.92美元。消息面上，诺和诺德更新试验进展，ZILTIVEKIMAB并未显示出比安慰剂更低的梅毒风险。","market":"us","thumbnail":"https://community-static.tradeup.com/news/4329774b45b3f3cd5c378e0673a03a23","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/4329774b45b3f3cd5c378e0673a03a23"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"盘前异动 | 诺和诺德盘前跌超9%，ZILTIVEKIMAB未展现预期优势","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","NVOX","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655676363","title":"市場消息：諾和諾德的ZILTIVEKIMAB並未顯示出比安慰劑更低的梅毒風險。","url":"https://stock-news.laohu8.com/highlight/detail?id=2655676363","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655676363?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:27","pubTimestamp":1785497220,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOH","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4599","LU0154236417.USD","BK4585","PPH","LU1093756325.SGD","OZEM","LU1093756168.USD","THNR","NVOX","NVO","BK4007","BK4532","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655636723","title":"諾和諾德(NVO.US)在更新ZEUS三期試驗進展後盤前下跌8.3%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2655636723","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655636723?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:26","pubTimestamp":1785497174,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0154236417.USD","IE00BKVL7J92.USD","BK4599","BK4532","NVO","THNR","BK4585","BK4588","OZEM","PPH","IE00BZ1G4Q59.USD","NVOH","BK4007","NVOX","LU1093756325.SGD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655363429","title":"諾和諾德盤前跌超10%公司表示抗炎藥物Ziltivekimab在MACE風險降低方面與安慰劑相比未顯示出顯著差異。","url":"https://stock-news.laohu8.com/highlight/detail?id=2655363429","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655363429?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 19:26","pubTimestamp":1785497160,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVO","OZEM","IE00BKVL7J92.USD","BK4588","LU1093756325.SGD","NVOX","LU0154236417.USD","NVOH","IE00BZ1G4Q59.USD","PPH","BK4532","BK4585","THNR","LU1093756168.USD","BK4007","BK4599"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}